EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High procalcitonin in Gram-negative urosepsis: indicator of immune modulation rather than poor outcome

Sebastian Petzoldt, Christina Buschhaus, Matthias Hecker, Arne Hauptmann, Florian Wagenlehner, Matthias Wolff, Martin Reichert, Veronika Grau, Andreas Hecker, Markus Weigand, Anca-Laura Amati

World Journal of Urology · 2026

DOI: 10.1007/s00345-026-06199-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Urology, 2026. Verfasst von Sebastian Petzoldt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Medicine, Giessen University Hospital, Justus-Liebig-University, Rudolf-Buchheim-Strasse 7, 35392, Gi…. Hauptthemen laut MEDLINE: Procalcitonin, Sepsis, Gram-Negative Bacterial Infections, Urinary Tract Infections. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Justus-Liebig-Universität Gießen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Procalcitonin (PCT) is an acute-phase protein and widely used marker for diagnosing bacterial infection and sepsis, but its physiological role remains incompletely defined. Interleukin-1β (IL-1β) is a critical mediator of the immune response to infection, whose excessive release can drive remote organ injury and dysfunction. Its secretion is therefore tightly controlled. Because other acute-phase proteins have been shown to regulate IL-1β secretion, we investigated whether PCT exerts a similar immunomodulatory effect and whether this influences sepsis severity, particularly in Gram-negative urosepsis.

Methods

Primary human mononuclear leukocytes were stimulated to induce IL-1β release in the presence or absence of increasing PCT concentrations. In parallel, peak PCT levels, infection source, and causative pathogen were analyzed retrospectively in uroseptic patients in comparison to other septic sources, and related to Sepsis-related Organ Failure Assessment (SOFA) scores and serum lactate concentrations.

Results

PCT significantly inhibited IL-1β secretion from primary mononuclear leukocytes across the 2.5–75 µg/L concentration range. Clinically, the highest PCT peaks occurred in patients with Gram-negative urosepsis. Among these, those with peak PCT values within 2.5–75 µg/L had significantly lower SOFA scores and lactate levels—established indicators of sepsis severity and prognosis—compared with patients outside this range.

Conclusion

Within a defined concentration range, PCT down-regulates IL-1β secretion and is associated with reduced markers of disease severity in Gram-negative urosepsis, compared to other sepsis entities. These findings suggest that pronounced PCT elevations in this setting may represent a protective host response rather than a worse prognosis, pointing to a novel immunomodulatory role of PCT in urosepsis that warrants further investigation. DRKS00037950, retrospectively registered on 22 September 2025.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProcalcitoninSepsisGram-Negative Bacterial InfectionsUrinary Tract InfectionsImmunomodulationHumansInterleukin-1betaRetrospective StudiesFemaleBiomarkersMaleMiddle AgedPrognosisAgedLeukocytes, MononuclearSeverity of Illness Index

Stichwörter der Autor:innen

Gram-negative urosepsisImmune modulationInterleukin-1βProcalcitoninSepsis severity

Substanzen

ProcalcitoninInterleukin-1betaBiomarkers

Autor:innen und Institutionen

  • Department of Anesthesiology and Intensive Care Medicine, Giessen University Hospital, Justus-Liebig-University, Rudolf-Buchheim-Strasse 7, 35392, Giessen, Germany.
  • Department of General, Visceral, Thoracic and Transplant Surgery, Giessen University Hospital, Justus-Liebig-University, Giessen, Germany.
  • Department of Internal Medicine II - Pulmonology, Giessen University Hospital, Justus-Liebig-University, Giessen, Germany.
  • Department of Urology, Pediatric Urology and Andrology, Giessen University Hospital, Justus-Liebig-University, Giessen, Germany.
  • Department of Anesthesiology, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Department of General, Visceral, Thoracic and Transplant Surgery, Giessen University Hospital, Justus-Liebig-University, Giessen, Germany. Anca-Laura.Amati@chiru.med.uni-giessen.de.

Förderung

  • Justus-Liebig-Universität Gießen

Zitieren

APA

Petzoldt, S., Buschhaus, C., Hecker, M., Hauptmann, A., Wagenlehner, F., Wolff, M., Reichert, M., Grau, V., Hecker, A., Weigand, M., & Amati, A. L. (2026). High procalcitonin in Gram-negative urosepsis: indicator of immune modulation rather than poor outcome. World Journal of Urology. https://doi.org/10.1007/s00345-026-06199-2

Vancouver

Petzoldt S, Buschhaus C, Hecker M, Hauptmann A, Wagenlehner F, Wolff M, et al. High procalcitonin in Gram-negative urosepsis: indicator of immune modulation rather than poor outcome. World Journal of Urology. 2026. doi:10.1007/s00345-026-06199-2

BibTeX
@article{Petzoldt2026,
  author = {Petzoldt, Sebastian and Buschhaus, Christina and Hecker, Matthias and Hauptmann, Arne and Wagenlehner, Florian and Wolff, Matthias and Reichert, Martin and Grau, Veronika and Hecker, Andreas and Weigand, Markus and Amati, Anca-Laura},
  title = {High procalcitonin in Gram-negative urosepsis: indicator of immune modulation rather than poor outcome},
  journal = {World Journal of Urology},
  year = {2026},
  doi = {10.1007/s00345-026-06199-2}
}
Kostenlos starten →